These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 11685487
1. Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector. Benjegård SA, Forssell-Aronsson E, Wängberg B, Skånberg J, Nilsson O, Ahlman H. Eur J Nucl Med; 2001 Oct; 28(10):1456-62. PubMed ID: 11685487 [Abstract] [Full Text] [Related]
2. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. Wangberg B, Forssell-Aronsson E, Tisell LE, Nilsson O, Fjalling M, Ahlman H. Br J Cancer; 1996 Mar; 73(6):770-5. PubMed ID: 8611378 [Abstract] [Full Text] [Related]
3. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide. Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW. Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760 [Abstract] [Full Text] [Related]
4. Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection. Ahlman H, Wängberg B, Tisell LE, Nilsson O, Fjälling M, Forssell-Aronsson E. Br J Surg; 1994 Aug; 81(8):1144-9. PubMed ID: 7953343 [Abstract] [Full Text] [Related]
6. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide. Bangard M, Béhé M, Guhlke S, Otte R, Bender H, Maecke HR, Biersack HJ. Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448 [Abstract] [Full Text] [Related]
8. Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer. Skånberg J, Ahlman H, Benjegård SA, Fjälling M, Forssell-Aronsson EB, Hashemi SH, Nilsson O, Suurkula M, Jansson S. Breast Cancer Res Treat; 2002 Jul; 74(2):101-11. PubMed ID: 12186370 [Abstract] [Full Text] [Related]
9. Evaluation of three gamma detectors for intraoperative detection of tumors using 111In-labeled radiopharmaceuticals. Benjegård SA, Sauret V, Bernhardt P, Wängberg B, Ahlman H, Forssell-Aronsson E. J Nucl Med; 1999 Dec; 40(12):2094-101. PubMed ID: 10616891 [Abstract] [Full Text] [Related]
10. 111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours. Hashemi SH, Benjegård SA, Ahlman H, Wängberg B, Forssell-Aronsson E, Billig H, Nilsson O. Br J Surg; 2003 May; 90(5):549-54. PubMed ID: 12734860 [Abstract] [Full Text] [Related]
12. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy. Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M. Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448 [Abstract] [Full Text] [Related]
17. [The scintigraphy of somatostatin receptors in the carcinoid tumor]. Banzo J, Abós MD, Prats E, Delgado M, Razola P, García S, Gomollón F, García F. Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324 [Abstract] [Full Text] [Related]
20. Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors. Janson ET, Westlin JE, Ohrvall U, Oberg K, Lukinius A. J Nucl Med; 2000 Sep; 41(9):1514-8. PubMed ID: 10994731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]